Product Name: BPC-157/TB-500 BLEND Strength: 20mg Total Peptide Content Blend Composition: BPC-157 10mg TB-500 10mg Chemical Name: Multi-Peptide Research Blend (BPC-157 + TB-500) Appearance: White to Off-White Lyophilized Powder Classification: Multi-Peptide Research Compound Purity: Verified by analytical testing prior to release Analytical Methods: HPLC, Mass Spectrometry (MS) Research areas commonly associated with this compound include: Tissue Repair Healing & Inflammation Store lyophilized material refrigerated at 28C for routine storage
My brain fog, which I had been suffering with since a surgery in 2018 is pretty much gone gives me a good energy boost in the afternoon Awesome product- A+++++++++ Very good gave me the right energy I needed Vitastir is the BEST
[PubMed Central ID: PMC46006]
Recent GLP-1 Weight Loss Drug Market Developments: Novo Nordisk, Eli Lilly, Amgen, and FDA Lead 20252026 April 2026: Eli Lilly submitted the orforglipron New Drug Application to the FDA for obesity treatment, reporting 14.7% body weight reduction in the ATTAIN-WEIGHT1 Phase 3 trial at the 45mg dose the first oral small molecule GLP-1 receptor agonist NDA submission for dedicated obesity pharmacological treatment in the United States
March 24, 2025
Strains of these bacteria have also been linked to weight loss, though we need clinical trials to develop recommendations for probiotics and weight loss